KYMR peer analysis
Kymera Therapeutics (KYMR) against its competitors: price, today's move, 1-year return and market value side by side.
KYMR and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARVN Arvinas | $6.39 | -2.44% | -33.02% | $428.93M |
| CCCC C4 Therapeutics | $3.14 | 6.44% | 30.38% | – |
| GLUE Monte Rosa Therapeutics | $10.57 | 3.12% | -14.22% | – |
| NRIX Nurix Therapeutics | $15.07 | 1.55% | 23.48% | – |
| KYMR Kymera Therapeutics | $131.07 | 2.30% | 119.79% | – |
- KYMR's peers: ARVN (Arvinas), CCCC (C4 Therapeutics), GLUE (Monte Rosa Therapeutics), NRIX (Nurix Therapeutics).
Updated 2026-11-07 11:56 UTC